Cargando…
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
Epilepsy is a major health burden, calling for new mechanistic insights and therapies. CRISPR-mediated gene editing shows promise to cure genetic pathologies, although hitherto it has mostly been applied ex vivo. Its translational potential for treating non-genetic pathologies is still unexplored. F...
Autores principales: | Colasante, Gaia, Qiu, Yichen, Massimino, Luca, Di Berardino, Claudia, Cornford, Jonathan H, Snowball, Albert, Weston, Mikail, Jones, Steffan P, Giannelli, Serena, Lieb, Andreas, Schorge, Stephanie, Kullmann, Dimitri M, Broccoli, Vania, Lignani, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089667/ https://www.ncbi.nlm.nih.gov/pubmed/32129831 http://dx.doi.org/10.1093/brain/awaa045 |
Ejemplares similares
-
Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome
por: Valassina, Nicholas, et al.
Publicado: (2022) -
Direct Neuronal Reprogramming Reveals Unknown Functions for Known Transcription Factors
por: Colasante, Gaia, et al.
Publicado: (2019) -
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
por: Weston, Mikail, et al.
Publicado: (2019) -
Direct Conversion of Fibroblasts into Functional Astrocytes by Defined Transcription Factors
por: Caiazzo, Massimiliano, et al.
Publicado: (2014) -
Designer receptor technology for the treatment of epilepsy
por: Lieb, Andreas, et al.
Publicado: (2019)